Renaissance Technologies LLC lowered its stake in shares of Anthem, Inc. (NASDAQ:ANTX – Free Report) by 41.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 198,800 shares of the company’s stock after selling 139,800 shares during the quarter. Renaissance Technologies LLC owned 0.55% of Anthem worth $680,000 as of its most recent filing with the Securities and Exchange Commission.
Analysts Set New Price Targets
Several analysts have recently weighed in on ANTX shares. Leerink Partners raised Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 target price for the company in a report on Thursday, May 14th. Wall Street Zen upgraded Anthem from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of Anthem in a research report on Monday, July 6th. Finally, Guggenheim assumed coverage on shares of Anthem in a research note on Monday, July 20th. They issued a “buy” rating and a $9.00 price objective on the stock. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $9.00.
Get Our Latest Stock Report on ANTX
Anthem Price Performance
Anthem (NASDAQ:ANTX – Get Free Report) last announced its earnings results on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.
About Anthem
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.
See Also
- Five stocks we like better than Anthem
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Want to see what other hedge funds are holding ANTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NASDAQ:ANTX – Free Report).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.
